Profile, risk practices and needs of people who inject morphine sulfate: Results from the ANRS-AERLI study
In France, a non-negligible proportion of opioid-dependent individuals inject morphine sulfate. Although it has not yet been officially approved as an opioid substitution treatment (OST), some physicians can prescribe its use for people in methadone or buprenorphine treatment failure. Longitudinal data from the ANRS-AERLI study, which evaluated an educational intervention for safer injection called AERLI, provided us the opportunity to better characterize the profile, risk practices and needs of people who inject morphine sulfate (MSI), through comparison with other injectors, and to identify correlates of HIV/HCV risk practices in this group.
Source: International Journal of Drug Policy - Category: Addiction Authors: Perrine Roux, Salim Mezaache, La élia Briand-Madrid, Marie Debrus, Nicolas Khatmi, Gwenaelle Maradan, Camélia Protopopescu, Daniela Rojas-Castro, Patrizia Carrieri Tags: Research Paper Source Type: research